about
Taxanes in the elderly patient with metastatic breast cancerPiperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast CancerSelection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cellsAptamer-targeted cell-specific RNA interferencePharmacokinetics, electrophysiological, and morphological effects of the intravitreal injection of mycophenolic acid in rabbitsA Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerPreparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.Docetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluation.Quantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MSComparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancerDepletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen.Lipid-coated gold nanocomposites for enhanced cancer therapyA novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistributionControlled Drug Delivery: Historical perspective for the next generation.Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.How nanotechnology can enhance docetaxel therapy.Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range.A traditional poly herbal medicine "Le Pana Guliya" induces apoptosis in HepG2 and HeLa cells but not in CC1 cells: an in vitro assessment.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication.Recent advances in drug delivery strategies for treatment of ovarian cancer.Taxane-Grafted Metal-Oxide Nanoparticles as a New Theranostic Tool against Cancer: The Promising Example of Docetaxel-Functionalized Titanate Nanotubes on Prostate Tumors.EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysisInjectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment.The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis.Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations.Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier.Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells.Photosensitivity reactions to vandetanib: redevelopment after sequential treatment with docetaxel.A Novel MPEG-PDLLA-PLL Copolymer for Docetaxel Delivery in Breast Cancer Therapy.Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer.Cetuximab infusion reactions: French pharmacovigilance database analysis.Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect.Solid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animal.Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery.Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution.
P2860
Q26785458-9A8C3516-F003-4100-B40F-E2725AF6A2A0Q28383510-108B36F0-3EA6-455A-92FD-7CC8E8CA2DC4Q30859838-64D63C4F-9717-4479-B4AB-5D59142A3B17Q33717239-36E61489-79F3-45F8-A986-40A0ABE58F3DQ33820065-89517D7C-13DD-40BD-B215-09F97EE65F70Q33949801-BCAB6BE8-7587-46B9-A627-57A00F60E4F9Q33949865-9B4C8B14-89EE-43FD-9F3A-DE2EC9C20611Q34674722-9CFE8352-8FC8-4D9E-8922-B33AE0B73F73Q34721483-4CD9CC79-594E-4A2B-A21C-778CBDC13B84Q35036060-632E6C6E-AEC6-4276-89E1-C9D19FADEE1EQ35214069-2CECC332-2ECD-4F9A-95E5-34C18AA51AADQ35227265-48A550D5-17F9-457A-A53E-EBA945AC37C4Q35598295-4FFF1B6D-23C9-426C-8AA7-E539DA4E5406Q35816288-E1721291-7C90-433D-A995-764F2EFF3ED8Q36010380-22FB0270-9238-41D7-9E3A-383FD5EED639Q36119564-F5C18B83-CD35-4AD7-834F-2E6B1AF4B286Q36307613-8E90E703-5C7E-4BC3-94DA-D7C6AAD4BD3DQ37074891-AFD2A9D0-B1CB-4B86-B62E-796F8E3104CFQ37091683-E5A009B4-5F3E-4159-92EA-BFB3922AFA17Q37549416-0884DEB2-7B25-4668-B742-65EE83BC3E44Q37560292-16532386-8F5F-47CD-9557-E0F63AC8E352Q37714256-0F47A2C3-4CBF-471C-B5A2-817E13B19E64Q37877271-BA6AA65D-90B9-4B46-B69C-ED96F142E75FQ37997512-A15B6905-7BE4-42A3-99BF-2CA6910442FEQ38703125-AC18F874-97B5-4DD2-82A5-8E62A9A79770Q38990966-E127B4EC-4E6F-487D-AB55-6981FD596E30Q39139831-88056D8C-0773-4962-A20A-1DA16FCE9C67Q39164622-2DB3B4DC-BF2D-4025-9F62-A2DF29FB79A3Q39192903-EE5907AC-1755-42FD-8B84-B50E0D545D28Q39537684-2D8EFA8A-646C-47E7-BFDE-753E66A8CBEAQ39579486-7BF20AB7-E315-43F1-97DF-C0204BA9FFE3Q39588223-AD20EB43-62AF-48FD-86F2-8DC71E6F5451Q41002305-ED2562CD-DE3F-477B-829B-50D026B6E0BCQ41430346-5A91EBAA-3A38-4CB2-82A9-C8621751B728Q46337679-BB87D0C9-0651-449C-954F-8BDC2F7156B6Q46370825-A5EFAEF4-5E17-489F-8526-C398B11D9DEBQ46396503-C4874A32-67D4-4790-9EDA-C7AB19DD0CA3Q46729488-68FED34C-1472-4E26-B893-BF7AE1695EAAQ47356287-39EADEEE-46AB-4A86-B32E-D63170D4CCE7Q48161831-C8DACC06-FB6B-43F1-9FA7-3F399987924D
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Alternative drug formulations of docetaxel: a review.
@ast
Alternative drug formulations of docetaxel: a review.
@en
Alternative drug formulations of docetaxel: a review.
@nl
type
label
Alternative drug formulations of docetaxel: a review.
@ast
Alternative drug formulations of docetaxel: a review.
@en
Alternative drug formulations of docetaxel: a review.
@nl
prefLabel
Alternative drug formulations of docetaxel: a review.
@ast
Alternative drug formulations of docetaxel: a review.
@en
Alternative drug formulations of docetaxel: a review.
@nl
P2093
P1433
P1476
Alternative drug formulations of docetaxel: a review.
@en
P2093
Frederike K Engels
Jaap Verweij
Ron A A Mathot
P304
P356
10.1097/CAD.0B013E3280113338
P577
2007-02-01T00:00:00Z